| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |